Are we doing enough? Navigating the changing landscape of mHSPC

Learning objective:         

After watching this broadcast, participants should be able to:

• Understand advances in therapeutic options in mHSPC and their impact on clinical practice
• Re-evaluate current clinical decision making and define best practice approaches to individualised care for patients with mHSPC

Scientific Committee:

• Alicia Morgans (USA)
• Axel Merseburger (Germany)

Faculty:

• Kim Chi (Canada)
• Steven Joniau (Belgium)
• Joe O’Sullivan (UK)